At myTomorrows, we're driven by a mission to enable earlier and better access to treatments while improving patients' lives. Our goal is to make it possible for anyone to find and access the best possible treatment options with just a click. We are revolutionizing how demand and supply connect in one of the world's largest industries. With our patient-centered offerings gaining significant traction, we aim to expand from helping thousands to millions of patients access new treatments each year. If you aspire to be at the forefront of patient-centric innovation and create the next industry unicorn, you've come to the right place!
As a QA Test Engineer, you will collaborate closely with our Product, Engineering, and other stakeholder teams to identify and report issues, recommend solutions, and ensure our products' overall quality and performance. Your expertise in test automation will be crucial in developing and maintaining automated test suites to ensure ongoing quality and performance. Additionally, you will develop and maintain test cases and documentation to ensure accurate and thorough testing coverage.
Considering that most of our team is based in the Netherlands, we are only considering candidates for this position who live within commuting distance of our Amsterdam office.
What you bring to the table:
We are fully cloud-native, primarily utilizing AWS services. Our development approach is Lean and API-first, leveraging cloud technologies and design practices. Our web front-end applications are developed in Angular, and our platform technologies, both microservice and AI, are developed in Python and deployed as AWS Lambda functions. We also have a growing expertise in knowledge graphs (Neo4j / Memgraph) and database technologies (SQL - AWS RDS, NoSQL – AWS DynamoDB, etc.). In addition, we develop human-in-the-loop Machine Learning for Healthcare in-house, leveraging LLMs and other NLP techniques.
myTomorrows aims to break barriers for eligible patients seeking information about clinical trials and support referrals to trial sites. When patients are not eligible for clinical studies, we help them and their physicians navigate the complexities of expanded access programs.
We